21 C.F.R. § 864.7720

Prothrombin consumption test.

Last amended: 2019Year: 2026Length: 97 wordsSubsections: 1Official source

Cite as 21 C.F.R. § 864.7720 (2026)

(a) Identification. A prothrombin consumption tests is a device that measures the patient's capacity to generate thromboplastin in the coagulation process. The test also is an indirect indicator of qualitative or quantitative platelet abnormalities. It is a screening test for thrombocytopenia (decreased number of blood platelets) and hemophilia A and B. (b) Classification. Class II (special controls). The device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 864.9. [45 FR 60625, Sept. 12, 1980, as amended at 84 FR 71800, Dec. 30, 2019]
Cross-references to the CFR
864.9.
21 C.F.R. § 864.7720: Prothrombin consumption test. | Justis AI